RESEARCH TRIANGLE PARK, N.C., Nov. 4, 2019 /PRNewswire/ -- T3D Therapeutics, a clinical stage drug development company engaged in the development of T3D-959, a new orally administered treatment for Alzheimer's disease (AD), announced today that it has closed on a $15 million financing from a cornerstone investor. These funds, along with supp

SANTA CLARA, Calif., Nov. 4, 2019 /PRNewswire/ -- In the quest to reduce costs and make optimal use of health systems, hospitals have increasingly consolidated into larger integrated delivery networks (IDNs). In medical imaging especially, providers that are looking to achieve true economies of scale and initiate a cycle of cost efficiency and growth a

WHITE PLAINS, N.Y., Nov. 4, 2019 /PRNewswire/ -- Acurx Pharmaceuticals, LLC ("Acurx" or the "Company"), a privately held, clinical stage, biopharmaceutical company developing new antibiotics for difficult-to-treat bacterial infections, announced today that it will present the Phase 1 clinical trial results for its lead antibiotic candidate, ACX-362E, under development fo

BREVARD, N.C., Nov. 4, 2019 /PRNewswire/ -- Raybow Pharmaceutical, a global pharmaceutical chemistry services provider, has acquired US-based PharmAgra Labs. 

MONMOUTH JUNCTION, N.J., Nov. 4, 2019 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its 

VANCOUVER, British Columbia, Nov. 4, 2019 /PRNewswire/ -- Sunniva Inc. ("Sunniva", the "Company", "we", "our" or "us") (CSE:SNN) (OTCQB:SNNVF), a North American provider of cannabis products and services, announces Dave Lyle, Chief Financial Officer has resigned as an officer, effective November 1st, for pers

NASDAQ: CORV   TSX: CORV VANCOUVER, Nov. 4, 2019 /PRNewswire/ - Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today announced that the U.S. Food and Drug Administration (FDA) will hold a Cardiovascular and Renal Drugs Advisory Committee (CRDAC) meeting in connection

NEW YORK, Nov. 4, 2019 /PRNewswire/ -- Beyond Type 1, a nonprofit organization changing what it means to live with diabetes, and One Drop, a leader in the development of digital therapeutics sol

VANCOUVER, British Columbia, Nov. 4, 2019 /PRNewswire/ -- Sunniva Inc. ("Sunniva", the "Company") (CSE:SNN, OTCQB:SNNVF) announces that it continues to work with CannaPharmaRx with respect to the to the sale of Sunniva Medical Inc. ("SMI") to CannaPharmaRx (the "SMI Transaction") and are confident that the SMI Transaction will be completed.

HAYWARD, Calif., Nov. 4, 2019 /PRNewswire/ -- Paragon Genomics, Inc., a leader in amplicon-based target enrichment solutions for next-generation sequencing (NGS), today announced the upcoming introduction of two new products at the 2019 Association for Molecular Pathology (AMP) Annual Meeting & Expo—a CleanPlex® CFTR Panel for cystic fibrosi